Compounds > 2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid
Page last updated: 2024-09-03

2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid and Hypertension

2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid has been researched along with Hypertension in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C1

Other Studies

1 other study(ies) available for 2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid and Hypertension

ArticleYear
Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium.
    The Journal of membrane biology, 2004, Jun-01, Volume: 199, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Catecholamines; Epinephrine; Female; Fura-2; Humans; Hypertension; In Vitro Techniques; Isoproterenol; Lymphocytes; Magnesium; Male; Propranolol

2004